| Q34214090 | Addressing standards of care in resource-limited settings |
| Q35086849 | Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach: Table 1 |
| Q57942541 | Ethical imperative of posttrial access to antiretroviral treatment |
| Q35679041 | Evaluating community engagement in global health research: the need for metrics |
| Q30504870 | Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya |
| Q27024941 | Framing the social in biomedical HIV prevention trials: a 20-year retrospective |
| Q34172218 | Impact of HIV/AIDS on mothers in southern India: a qualitative study |
| Q33509404 | Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania |
| Q40015302 | Perceptions and health care needs of HIV-Positive mothers in India |
| Q43944983 | Private sector response to HIV/AIDS in Tanzania |
| Q58595713 | Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence |
| Q30584402 | Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials |
| Q43009532 | The exploitation of "Exploitation" in the tenofovir prep trial in Cameroon: Lessons learned from media coverage of an HIV prevention trial |